Chronic Obstructive Pulmonary Disease Flashcards
1
Q
- Pathological and radiographic term that describes structural changes associated with COPD
- abnormal and permanent enlargement of airspaces distal to terminal bronchioles (respiratory bronchiole, alveolar ducts, alveolar sacs and alveoli) that is accompanied by destruction of the airspace walls
- this results in ariway collapse due to loss of tethering of the airways open as the alveoli are destroyed
A
Emphysema
2
Q
risk factors for COPD?
A
tobacco use
- cigarette smokin is leading environmental risk, however even for heavy smokers < 50% develop COPD
E-cigarrettes
genetic risk factors
gender differences
occupational/ environmental exposures
3
Q
what are some things to note about women and COPD?
A
- COPD is leading cause of death among female smokers ahead of lung cancer and cardiovascular disease
- often more delayed diagnosis than in men- depression and fatigue mae distract from underlying lung disease
- more likely to have coexisting anxiety, depression, heart failure, osteoporosis
4
Q
symptoms and physical exam findings in COPD?
A
Symptoms
- Dyspnea
- cough
- sputum production
- wheezing and chest pain
PE:
- prolonged expiration or wheezing with forced exhalation
- more advanced disease: hyperinfation- barrel shaped chest (increased AP diameter) depressed diaphragm
- wheezing
- distant heart sounds
5
Q
what are some end-stage physical exam finding in COPD?
A
- Tripod positioning
- use of accessory respiratory muscles of neck and shoulder girdle
- pursed lip breathing
- cyanosis
- muscle wasting
6
Q
diagnosis of COPD?
A
- all pts newly diagnosed with COPD should be screened for a1at deficiency
- PFT are required to make the diagnosis of COPD
- spirometry is used to idenify obstruction and to grade severity of disease
- diffusion capacity (DLCO) is often reduced, particularly in patients with extensive emphysema
- expiratory limb of the flow-volumve curve will have scooping
7
Q
Prognostic factors of COPD
A
- FEV1
- ongoing tobacco use
- BMI- less than 21 is asscoiated with increased mortality
- age
- frequency of exacerbations and severity exacerbations
- chronic hypercapnia
- presence of comorbid conditions- lung cancer, cardiovascular disease, sleep-related breathing, diabetes, osteoporosis, cognitive dysfunction, psychiatric illness
8
Q
- only therapeutic intervention that impats mortality in COPD long term
- never withold due to CO2 concerns
- Pa02 < 55mmg or SaO2 < 88%
- consistenly improves exrecise capacit in lab-based exercise tests, but effects on dyspnea were variable
- if patients are started in the setting of hospitalization or exacerbation, re-evaluate in 4-8 weeks for ongoing needs
A
oxygen therapy
9
Q
- acute change (< 14 days of symptoms) in baseline respiratory status
- one or more of the following cardinal symptoms:
- cough increases in frequency and severity
- sputum production increases in volume and/or changes character
- increase in dyspnea
A
acute exacerbation of COPD
10
Q
risk factors for exacerbations in COPD?
A
- Advanced age
- severity of FEV1 impairment
- chronic sputum production
- frequent prior exacerbations
- hospitalization w/in past year
- comorbidities (CAD, CHF, DM)
11
Q
Diagnsotic studies for exacerbation of COPD?
A
- chest radiograph (for eD or hospital admits)
- spriometry-
- ABG
- pulse oximetry
- sputum cultures
- +/- respiratory viral PCR panel
- BNP
- d-dimer
- procalcitonin
12
Q
etiology/trigger of AECOPD?
A
Infectious (80%)
- bacterial
- viral
- co infection
- atypical bacteria
noninfectious
- environmental exposures (NO2, SO2, ozone, particulates)
- nonadherence to medications